DRUG · Mapped RxNorm record
raloxifene
Normalized identity: raloxifeneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Raloxifene in Preventing Breast Cancer in Premenopausal Women
NCT00019500
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
PROCEDURE · Unmapped registry intervention
evaluation of cancer risk factors
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedRaloxifene in Preventing Breast Cancer in Premenopausal Women
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
raloxifeneDRUG · verified · RxNorm: raloxifene
evaluation of cancer risk factorsPROCEDURE
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00019500 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.